INTRODUCTION
Mucodhesion is a promising approach in the design of drug delivery systems to prolong the residence time of the dosage form the site of application or absorption and to facilitate intimate contact of the dosage form with the underlying absorption surface to improve and enhance the bioavailability of drugs 1 . Several studies reported mucodhesive drug delivery systems in the form of tablet, films, patches and gels for oral, buccal, nasal, occular and topical routes.
Levofloxacin hydrochloride is a fluoroquinolone antibacterial drug, which is used in the various kinds of infections like urinary tract infections, gonorrhoea vaginitis etc 2 . It has very bitter taste and is readily soluble in the gastric pH due to the formations of salt. The drug is also reported to have poor stability at elevated temperatures and exposure to sunlight, due to the ring opening and formation of ethylene diamine and formamide derivative 3 . To over come with these problems, mucoadhesive microspheres of Levofloxacin were formulated using Sodium Alginate, Sodium Carboxymethyl Cellulose and Carbopol-940 polymers. These mucoadhesive polymers in the microspheres prolong the residence time of the dosage form in the gastrointestinal tract and hence are more suitable as matrix material for oral controlled release 4 .
MATERIALS AND METHODS
Levofloxacin hydrochloride was a gift sample from Cipla Ltd. Mumbai. Sodium Carboxymethyl Cellulose (1500-400cps) was procured from Central Drug House, Mumbai. Carbopol-940 and Sodium Alginte was procured from Loba Chemie, Mumbai. Light liquid paraffin and Span-20 were procured from commercial sources. All other reagents used were of analytical grade.
Preparation of mucoadhesive microspheres:
Microspheres were prepared by the water-in-oil (w/o) emulsification solvent evaporation technique. The model drug was dissolved in each polymeric aqueous solutions.
The solutions were poured into 200 g of mineral oil containing 0.5% span -20 as an emulsifying agent. The aqueous phase was emulsified into the oily phase by stirring the system in a 500 ml beaker. Constant stirring at 2000 rpm was carried out using mechanical stirrer (Remi, Model No.FTQ 124A). The beaker and its content were heated by an on the hot plate at 80 o C. Stirring and heating were maintained for 4.5 h until the aqueous phase was completely removed by evaporation. The light mineral oil was decanted and collected microspheres were washed three times with 100 ml aliquots of n-hexane, filtered through Whatman filter paper, dried in an oven at 50 o C for 2 h and stored in a desiccator at room temperature. Microspheres were prepared using Sodium Alginate, Sodium Carboxymethyl Cellulose and Carbopol-940 polymers 5 . Compositions of formulation(s) are shown in Table 1 .
Drug content
Levofloxacin content in the microspheres was estimated by a UV Spectrophotometric (Thermospectronic Model No.156) method based on the measurement of absorbance at 280 nm in distilled water. Microspheres equivalent to 50 mg were weighed and added in 100 ml of distilled water. The volumetric flask was stirred continuously for 24 h on a magnetic stirrer. Dilutions of above solutions were made suitably and measured for the drug content.
Particle size:
Particle size analysis was performed with the help of optical microscopy for all the formulations.
In-Vitro Drug Release Study:
Release of Levofloxacin HCI from the microspheres was studied in distilled water using USP XXIII Six station dissolution test apparatus (Thermospectronic Model No.156) with rotating basket at 100 rpm and at 37 o C.
For each formulation, Microspheres equivalents to 100 mg of Levofloxacin were filled in empty capsule shells. One capsule was used in each test and placed in the basket. Samples of dissolution fluid were withdrawn at different intervals, filtered and diluted suitably and then analyzed spectrophotometrically at 280 nm.
( Fig.1, 2) show the graphical representation of in-vitro release profile from the formulations 6 .
In -Vitro Test for Mucoadhesion:
The mucoadhesion property of the microspheres was evaluated by a modified in-vitro wash off test method. Pieces of the intestinal mucosa (3 cm x 1 cm) were mounted on to glass rods (4 cm x 1 cm) and placed in the tubes of USP Tablet disintegrating test apparatus. 50 microspheres were spread on to each wet rinsed pieces of intestinal mucosa in distilled water 7 . The tissue specimen was given a slow regular up and down movement in the test fluid at 37 o C, up to 3.5 h, after each half a hour the machine was stopped and the number of microspheres adhering on to the tissue were counted by using convex hand lens.
Stability Studies
Microspheres formulations were stored at three different temperatures of refrigerated, at room temperature and at 45 0 C for 42 days 8 . After six week of the storage of the microspheres Levofloxacin was analyzed in consecutive order for the drug content spectrophotometrically at 280 nm. Data of stability studies are shown graphicaly at different temperatures respectively.
RESULT AND DISCUSSION
Emulsion Solvent Evaporation Method using Sodium Carbooxymethyl Cellulose, Sodium Alginate and Carbopol-940 prepared the Mucoadhesive microspheres of Levofloxacin hydrochloride. Microspheres were designed using different ratios of the polymers as shown in Table  given below Table 2 shows drug content in all different Formulations were estimated by UV Spectrophotometric method, Percent loading efficiency were found in the range of 50-76 %.
Formulation F 2 containing carbopol-940 showed maximum percent loading of drug up to 76%. Formulation F 6 containing carbopol-940 / Sodium Alginate showed less percent loading of drug as compared to Formulation F 2 . Rank order of Percent loading was found to be as followed.
Particle size analysis of different formulations was done by optical microscopy. The average particle size was found to be in the range of 27.9 m -35.75 m. F 2 showed the least particle size of 27.9 m which is due to spherical nature of microspheres as showed by the SEM. Sodium alginate showed the largest particle size of 35.75 m, due to the irregular nature of the microspheres, confirmed by SEM.
In-vitro release studies of all the formulations containing drug were performed in distilled water at 280 nm. 5 and F 6 respectively. The linearity indicated that the drug release from the microspheres followed the matrix diffusion process.
The plots of log cumulative percent drug retained versus time were found to be linear for all the formulations his linearity indicates that the release of Levofloxacin from the microspheres have obeyed first order kinetics films might have followed first order kinetics. The correlation coefficient values were found to be -0.9770, -0.9454, -0.9915, -0.9969, -0.9906, -0.9867 for formulation F 1, F 2, F 3, F 4, F 5 and F 6 respectively. It shows that data are in good correlation. Negative values of the correlation coefficient indicate negative slope for the plot.
To assess the mucoadhesivity of the microspheres in-vitro wash off test was performed for all the formulations. At the end of 3.5 h Percent mucoadhesivity was found to be 30, 16, 4, 10, 10, 4 for formulation F 1, F 2, F 3, F 4, F 5 and F 6 respectively Table 3 . Formulation F 1 showed the highest percent mucoadhesion. The greater mucoadhesivity of the SCMC microspheres were due to anionic nature of the polymer, and sodium alginate showed the lowest percent mucoadhesion due to the irregular surface microspheres prepared by it. The rank order of mucoadhesion for the formulations were as found to be F1>F 2 >F 4 >F 5 > F 6 > F 3 .The mucoadhesion profile of the formulations is depicted in for the study period of 3.5 h 
The stability studies of formulations were performed at three different temperature (refrigerated temperature, room temperature and 45 0 C) for six week after 7, 14, 21`, 28, 35 and 42 day of storage the drugs content in the microspheres were determined. Fig.4 ,5 and 6
It was found that at refrigerated temperature microspheres are stable as compared that in room temperature and 45 0 C. Microspheres showed maximum loss of drug content at 45 0 C due to the enhanced rate of degradation of Levofloxacin at elevated temperature. It was concluded that incorporation of drug into the polymeric matrix of microspheres improved the stability of the drug. Formulation F 1 showed the best stability profile at refrigerated and at room temperature while at elevated temperature decrease in the stability was observed. It was found that the formulation F 2, F 3 and F 5 showed the good stability profile as compared to other formulations at the same conditions. Among the mucoadhesive microspheres of Levofloxacin hydrochloride prepared using SCMC, sodium Alginate and Carbopol-940 polymers, the formulations F 1 and F 2 containing SCMC and CP-940 showed reproducible results and the best mucoadhesive profile with good surface morphology. Formulation F 2 (Carbopol-940), F 3 (Sodium alginate) and F 5 (SCMC / Sodium alginate) microspheres showed the optimum, sustained release pattern as well as the good stability profile.
